Evaluation and comparison of two new prostate carcinoma markers: Free- prostate specific antigen and prostate specific membrane antigen

Cancer

Volumn 78, Issue 4, 1996, Pages 809-818

  Murphy, Gerald P ^a,g   Barren, Robert J ^a   Erickson, Sheila J ^a   Bowes, Victoria A ^a   Wolfert, Robert L ^b   Bartsch, Georg ^c   Klocker, Helmut ^c   Pointner, Joseph ^c   Reissigl, A ^c   McLeod, David G ^d,e,f   Douglas, Thomas ^d,e   Morgan, Ted ^d,e   Kenny, Gerald M ^a   Ragde, Haakon ^a   Boynton, Alton L ^a   Holmes, Eric H ^a  

^a NORTHWEST HOSPITAL   (United States)

^b Hybritech Incorporated   (United States)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^f Center for Prostate Disease Research   (United States)

^g PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

free prostate specific antigen; prostate specific antigen; prostate specific membrane antigen

Indexed keywords

MEMBRANE ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC;

ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; BIOPSY; EVALUATION STUDIES; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 9444280215     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960815)78:4<809::AID-CNCR18>3.0.CO;2-Z     Document Type: Article

References (22)

1. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Invest Urol 1979; 17:159-63.
2. Murphy GP. The second Stanford conference on international standardization of PSA assays. Cancer 1995;75(1):1-7.
3. Murphy GP, Holmes EH, Boynton AL, Kenny GM, Ostenson RC, Erickson SJ, et al. A comparison of prostate specific antigen, prostate specific membrane antigen and LNCap based ELISA assays in prostatic cancer patients and patients with benign prostatic enlargement. Prostate 1995;26:164-8.
4. Murphy GP, Ragde H, Kenny G, Barren R III, Erickson S, Tjoa B, et al. Comparison of prostate specific membrane antigen, and prostate specific antigen levels in prostatic cancer patients. Anticancer Res 1995;15:1473-80.
5. Douglas TH, Connelly RR, McLeod DG, Erickson SJ, Barren RI, Murphy GP. The effects of exogenous testosterone replacement on prostate specific antigen and prostate specific membrane antigen levels in hypogonadal men. J Surg Oncol 1995;59:246-50.
6. Rochon YP, Horoszewicz JS, Boynton AL, Holmes EH, Barren RJ, Erickson SJ, et al. Western blot assay for prostate specific membrane antigen in serum of prostate cancer patients. Prostate 1994;25:219-23.
7. Catalona W, Smith D, Wolfert R, Wang T, Rittenhouse H, Ratliff T, et al. Evaluation of percentage of free serum prostate specific antigen to improve specificity of prostate cancer screening. JAMA 1995;274(15):1214-20.
8. Stenman U, Hakama M, Knekt P, Aromaa A, Teppo L, Leinonen J. Serum concentration of prostate specific antigen and its complex with a-1-antichymotrypsin before diagnosis of prostate cancer. Lancet 1994;344:1594-8.
9. Wu J, Wilson L, Zhang P, Meikle A, Stephenson R. Correlation of PSA-ACT complex with total PSA in random and serial specimens from patients with BPH and prostate cancer. J Clin Lab Anal 1995;9:15-24.
10. Luder A, Cen Y, Soriano T, Kramp W, Carlson G, Cuny C, et al. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic grey zone of total prostate-specific antigen. Urology 1995;46(2):187-94.
11. Bangma C, Ries K, Blijenberg B, Schröder F. The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men. Urology 1995;46(6):773-8.
12. Bangma C, Ries K, Blijenberg B, Schröder F. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis ratio, age-specific ranges, and PSA density. Urology 1995;46(6):779-84.
13. Lilja H, Christensson A, Dahlen U, Matikinen MT, Nilsson O, Pettersson K, et al. Prostate specific antigen in serum occurs predominately in complex with Alpha- 1-antichymotrypsin. Clin Chem 1991;37:1618-25.
14. Stenman U-H, Leinaon J, Alfthan H, Rannikko S, Tuhkaren K, Alfthan O. A complex between prostate-specific antigen and Alpha- 1-Antichymotypsin is the major form of prostate-specific antigen in serum of patients with prostate cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51:222-6.
15. Graves H. Standardization of immunoassays for prostate specific antigen (PSA): a problem of PSA complexation or a problem of assay design? Cancer 1993;72:3141-4.
16. Slack N, Murphy G. Criteria for evaluating patient responses to treatment modalities for prostate cancer. Urol Clin North Am 1984;11:337-42.
17. Mettlin C, Murphy G, Babaian R, Chesley A, Kane R, Littrup P, et al. The results of a five year early prostate detection intervention. Cancer 1996;77:150-9.
18. Pfaffenberger RC, Paterson JH. Statistical methods for business and economics. Richard Irwin, Inc., 1977.
19. Tillyer CR, Konings M, Gobin PT, Iqbal J. Disagreement between the Roche Cobas Core and Hybritech Tandem-E PSA assays when measuring free, complexed and total serum prostate specific antigen. Ann Clin Biochem 1994;31:501-5.
20. DeLeo J. Receiver operating characteristic laboratory (ROCLAB): software for developing decision strategies that account for uncertainty. Second International Symposium on Uncertainty Modeling Analysis, IEEE Computer Society Press 1993:318-25.
21. Metz CE. Basic Principles of ROC Analysis. Semin Nucl Med 1978;4:283-98.
22. Murphy G, Tino B, Holmes E, Boynton A, Erickson S, Bowes T, et al. Measurement of Prostate Specific Antigen in the serum with a new antibody. Prostate 1996;28:266-71.